DocuSign’s first quarter results surpassed Wall Street’s revenue and profit expectations, yet the market reacted negatively due to concerns around billings growth and the timing of early renewals. Management pointed to the impact of go-to-market changes, particularly a new sales incentive structure that accelerated the shift away from early renewals, as a key factor. CEO Allan Thygesen described the quarter as one of “foundational change” for DocuSign, emphasizing the strong adoption of its Intelligent Agreement Management (IAM) platform but acknowledging that billings ended below guidance due to the timing of renewals rather than underlying demand.
Is now the time to buy DOCU? Find out in our full research report (it’s free).
DocuSign (DOCU) Q1 CY2025 Highlights:
- Revenue: $763.7 million vs analyst estimates of $748.1 million (7.6% year-on-year growth, 2.1% beat)
- Adjusted EPS: $0.90 vs analyst estimates of $0.81 (10.5% beat)
- Adjusted Operating Income: $225 million vs analyst estimates of $207 million (29.5% margin, 8.7% beat)
- The company slightly lifted its revenue guidance for the full year to $3.16 billion at the midpoint from $3.14 billion
- Operating Margin: 7.9%, up from 3.2% in the same quarter last year
- Billings: $739.6 million at quarter end, up 4.2% year on year
- Market Capitalization: $15.43 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions DocuSign’s Q1 Earnings Call
-
Jacob Roberge (William Blair): Asked about the drivers and timing of lower early renewals and the broader health of the business. CEO Allan Thygesen and CFO Blake Grayson explained that changes to sales incentives led to fewer early renewals in Q1 and that IAM adoption and customer retention remain healthy.
-
Tyler Radke (Citi): Questioned confidence in second-half billings acceleration and the impact of early renewals. Thygesen stated that commercial segment scaling, rather than dramatic enterprise gains, underpins the forecast, while Grayson noted additional conservatism in renewal assumptions.
-
Robbie Owens (Piper Sandler): Asked if lower billings were purely a timing issue and whether increased sales capacity would yield future upside. Thygesen clarified that deal size has not been affected and described efforts to reallocate sales resources to higher-potential opportunities.
-
Joshua Baer (Morgan Stanley): Sought detail on how much IAM growth comes from upsells versus new customers, and the impact of nonrecurring revenue items. Grayson said the largest opportunity is upselling to the existing customer base, with some growth also from new clients, and noted that nonrecurring items were not significant contributors.
-
Brad Sills (Bank of America): Inquired about early evidence that deeper account focus is increasing deal size and pipeline quality. Thygesen responded that early signs of larger IAM deals are positive but that the shift is still in its early stages.
Catalysts in Upcoming Quarters
In the next few quarters, the StockStory team will be watching (1) whether IAM adoption continues to accelerate, especially among large enterprise clients; (2) signs that international and partner-driven growth are contributing meaningfully to revenue; and (3) stabilization in billings growth as the impact of renewal timing normalizes. The success of upcoming IAM feature releases and the company’s ability to maintain operational efficiency will also be important indicators.
DocuSign currently trades at $76.66, down from $93 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free).
High-Quality Stocks for All Market Conditions
Donald Trump’s victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.
While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.